Company intelligence / Profile preview

Avivomed

San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

Avivomed is a medical technology company that develops leadless, wirelessly powered neuromodulation systems. Its technology aims to treat chronic pain by delivering electrical stimulation to specific nerves without the need for traditional leads or bulky implanted batteries. This approach is designed to simplify the surgical procedure and reduce long-term complications such as lead migration or fracture. The company was acquired by LivaNova in April 2022 to expand its portfolio in the neuromodulation market. Avivomed's platform is currently being integrated into LivaNova's broader neurological therapy offerings to address unmet needs in pain management.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

LivaNova

Beyond the preview

Go deeper on Avivomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avivomed.

Explore the full profile